Atlas of Genetics and Cytogenetics in Oncology and Haematology


Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

CD99 (CD99 molecule)

Identity

Other namesHBA71
MIC2
MIC2X
MIC2Y
MSK5X
HGNC (Hugo) CD99
LocusID (NCBI) 4267
Atlas_Id 997
Location Xp22.33
Location_base_pair Starts at 2609228 and ends at 2659350 bp from pter ( according to hg19-Feb_2009)
Fusion genes
(updated 2016)
CD99 (Xp22.33) / EWSR1 (22q12.2)CD99 (Xp22.33) / FLII (17p11.2)CD99 (Xp22.33) / PDIK1L (1p36.11)

Note

Non-annotated gene. Preliminary data : if you are an author
who wish to write a full paper/card on this gene, go to  How to contribute

DNA/RNA

 


Other Solid tumors implicated (Data extracted from papers in the Atlas) [ 4 ]
  Soft Tissues: Desmoid-type fibromatosis
Soft Tissues: Extraskeletal osteosarcoma
Bone: Sarcoma with inv(X)(p11.4p11.22) BCOR/CCNB3
Liver: Nested stromal epithelial tumor
Lung: Pleuropulmonary blastoma

External links

Nomenclature
HGNC (Hugo)CD99   7082
Cards
Entrez_Gene (NCBI)CD99  4267  CD99 molecule
AliasesHBA71; MIC2; MIC2X; MIC2Y; 
MSK5X
GeneCards (Weizmann)CD99
Ensembl hg19 (Hinxton)ENSG00000002586 [Gene_View]  chrX:2609228-2659350 [Contig_View]  CD99 [Vega]
Ensembl hg38 (Hinxton)ENSG00000002586 [Gene_View]  chrX:2609228-2659350 [Contig_View]  CD99 [Vega]
ICGC DataPortalENSG00000002586
TCGA cBioPortalCD99
AceView (NCBI)CD99
Genatlas (Paris)CD99
WikiGenes4267
SOURCE (Princeton)CD99
Genomic and cartography
GoldenPath hg19 (UCSC)CD99  -     chrX:2609228-2659350 +  Xp22.33   [Description]    (hg19-Feb_2009)
GoldenPath hg38 (UCSC)CD99  -     Xp22.33   [Description]    (hg38-Dec_2013)
EnsemblCD99 - Xp22.33 [CytoView hg19]  CD99 - Xp22.33 [CytoView hg38]
Mapping of homologs : NCBICD99 [Mapview hg19]  CD99 [Mapview hg38]
OMIM313470   450000   
Gene and transcription
Genbank (Entrez)AK309517 AK313617 BC002584 BC003147 BC010109
RefSeq transcript (Entrez)NM_001122898 NM_001277710 NM_001321367 NM_001321368 NM_001321369 NM_001321370 NM_002414
RefSeq genomic (Entrez)NC_000023 NC_000024 NC_018934 NG_009174 NT_167197 NT_167205 NW_004929438
Consensus coding sequences : CCDS (NCBI)CD99
Cluster EST : UnigeneHs.653349 [ NCBI ]
CGAP (NCI)Hs.653349
Alternative Splicing GalleryENSG00000002586
Gene ExpressionCD99 [ NCBI-GEO ]   CD99 [ EBI - ARRAY_EXPRESS ]   CD99 [ SEEK ]   CD99 [ MEM ]
Gene Expression Viewer (FireBrowse)CD99 [ Firebrowse - Broad ]
SOURCE (Princeton)Expression in : [Datasets]   [Normal Tissue Atlas]  [carcinoma Classsification]  [NCI60]
GenevisibleExpression in : [tissues]  [cell-lines]  [cancer]  [perturbations]  
BioGPS (Tissue expression)4267
GTEX Portal (Tissue expression)CD99
Protein : pattern, domain, 3D structure
UniProt/SwissProtP14209 (Uniprot)
NextProtP14209  [Sequence]  [Exons]  [Medical]  [Publications]
With graphics : InterProP14209
Splice isoforms : SwissVarP14209 (Swissvar)
PhosPhoSitePlusP14209
Domains : Interpro (EBI)CD99L2   
Domain families : Pfam (Sanger)CD99L2 (PF12301)   
Domain families : Pfam (NCBI)pfam12301   
DMDM Disease mutations4267
Blocks (Seattle)CD99
SuperfamilyP14209
Human Protein AtlasENSG00000002586
Peptide AtlasP14209
HPRD02434
IPIIPI00253036   IPI00645716   IPI00642948   IPI00220117   IPI00644034   IPI00643531   
Protein Interaction databases
DIP (DOE-UCLA)P14209
IntAct (EBI)P14209
FunCoupENSG00000002586
BioGRIDCD99
STRING (EMBL)CD99
ZODIACCD99
Ontologies - Pathways
QuickGOP14209
Ontology : AmiGOcytoplasm  plasma membrane  integral component of plasma membrane  focal adhesion  cell adhesion  
Ontology : EGO-EBIcytoplasm  plasma membrane  integral component of plasma membrane  focal adhesion  cell adhesion  
Pathways : KEGGCell adhesion molecules (CAMs)    Leukocyte transendothelial migration   
NDEx Network
Atlas of Cancer Signalling NetworkCD99
Wikipedia pathwaysCD99
Orthology - Evolution
OrthoDB4267
GeneTree (enSembl)ENSG00000002586
Phylogenetic Trees/Animal Genes : TreeFamCD99
Homologs : HomoloGeneCD99
Homology/Alignments : Family Browser (UCSC)CD99
Gene fusions - Rearrangements
Polymorphisms : SNP, variants
NCBI Variation ViewerCD99 [hg38]
dbSNP Single Nucleotide Polymorphism (NCBI)CD99
dbVarCD99
ClinVarCD99
1000_GenomesCD99 
Exome Variant ServerCD99
ExAC (Exome Aggregation Consortium)CD99 (select the gene name)
Genetic variants : HAPMAP4267
Genomic Variants (DGV)CD99 [DGVbeta]
Mutations
ICGC Data PortalCD99 
TCGA Data PortalCD99 
Broad Tumor PortalCD99
OASIS PortalCD99 [ Somatic mutations - Copy number]
Somatic Mutations in Cancer : COSMICCD99 
LOVD (Leiden Open Variation Database)Whole genome datasets
LOVD (Leiden Open Variation Database)LOVD 3.0 shared installation
LOVD (Leiden Open Variation Database)X-chromosome gene database
BioMutasearch CD99
DgiDB (Drug Gene Interaction Database)CD99
DoCM (Curated mutations)CD99 (select the gene name)
CIViC (Clinical Interpretations of Variants in Cancer)CD99 (select a term)
intoGenCD99
Impact of mutations[PolyPhen2] [SIFT Human Coding SNP] [Buck Institute : MutDB] [Mutation Assessor] 
Diseases
DECIPHER (Syndromes)X:2609228-2659350  ENSG00000002586
CONAN: Copy Number AnalysisCD99 
Mutations and Diseases : HGMDCD99
OMIM313470    450000   
MedgenCD99
Genetic Testing Registry CD99
NextProtP14209 [Medical]
TSGene4267
GENETestsCD99
Huge Navigator CD99 [HugePedia]
snp3D : Map Gene to Disease4267
BioCentury BCIQCD99
ClinGenCD99
Clinical trials, drugs, therapy
Chemical/Protein Interactions : CTD4267
Chemical/Pharm GKB GenePA30804
Clinical trialCD99
Miscellaneous
canSAR (ICR)CD99 (select the gene name)
Probes
Litterature
PubMed95 Pubmed reference(s) in Entrez
GeneRIFsGene References Into Functions (Entrez)
CoreMineCD99
EVEXCD99
GoPubMedCD99
iHOPCD99
Genes in titleautomatic search in PubMed
REVIEW articlesautomatic search in PubMed
Last year publicationsautomatic search in PubMed

Search in all EBI   NCBI

© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Sat May 28 10:57:07 CEST 2016

Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

For comments and suggestions or contributions, please contact us

jlhuret@AtlasGeneticsOncology.org.